Gene Expression Profiling in Postmortem Rett Syndrome Brain: Differential Gene Expression and Patient Classification

The identification of mutations in the transcriptional repressor methyl-CpG-binding protein 2 (MECP2) gene in Rett Syndrome (RTT) suggests that an inappropriate release of transcriptional silencing may give rise to RTT neuropathology. Despite this progress, the molecular basis of RTT neuropathogenesis remains unclear. Using multiple cDNA microarray technologies, subtractive hybridization, and conventional biochemistry, we generated comprehensive gene expression profiles of postmortem brain tissue from RTT patients and matched controls. Many glial transcripts involved in known neuropathological mechanisms were found to have increased expression in RTT brain, while decreases were observed in the expression of multiple neuron-specific mRNAs. Dramatic and consistent decreases in transcripts encoding presynaptic markers indicated a specific deficit in presynaptic development. Employing multiple clustering algorithms, it was possible to accurately segregate RTT from control brain tissue samples based solely on gene expression profile. Although previously achieved in cancers, our results constitute the first report of human disease classification using gene expression profiling in a complex tissue source such as brain.

[1]  S. Dhanjal,et al.  Mutation analysis of the MECP2 gene in British and Italian Rett syndrome females , 2001, Journal of Molecular Medicine.

[2]  S. Naidu.  Rett syndrome: A disorder affecting early brain growth , 1997, Annals of neurology.

[3]  P. Jonveaux,et al.  MECP2 mutations account for most cases of typical forms of Rett syndrome. , 2000, Human molecular genetics.

[4]  R. Mayer,et al.  Ubiquitin in Neurodegenerative Diseases , 1993, Brain pathology.

[5]  J. Goldman,et al.  Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice. , 1998, The American journal of pathology.

[6]  D. Schorderet,et al.  Methylation status of CpG sites and methyl-CpG binding proteins are involved in the promoter regulation of the mouse Xist gene. , 1998, Gene expression.

[7]  R. Mayer,et al.  Ballooned neurons in several neurodegenerative diseases and stroke contain alpha B crystallin. , 1992, Neuropathology and applied neurobiology.

[8]  L. Penland,et al.  Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.

[9]  A. Bird,et al.  DNA methylation and chromatin modification. , 1999, Current opinion in genetics & development.

[10]  Christian A. Rees,et al.  Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.

[11]  B Hagberg,et al.  Rett syndrome: 3‐D confocal microscopy of cortical pyramidal dendrites and afferents , 1994, Neuroreport.

[12]  W. Kaufmann,et al.  Abnormalities in neuronal maturation in Rett syndrome neocortex: preliminary molecular correlates. , 1997, European child & adolescent psychiatry.

[13]  D. Glaze,et al.  Substance P immunoreactivity in Rett syndrome. , 2000, Pediatric neurology.

[14]  A. Federico,et al.  MECP2 mutation in male patients with non‐specific X‐linked mental retardation , 2000, FEBS letters.

[15]  S. Cross,et al.  Gene silencing by methyl-CpG-binding proteins. , 1998, Novartis Foundation symposium.

[16]  H. Zoghbi,et al.  Molecular genetics of Rett syndrome and clinical spectrum of MECP2 mutations , 2001, Current opinion in neurology.

[17]  M. Bittner,et al.  Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. , 1998, Cancer research.

[18]  Jonathan Pevsner,et al.  DRAGON: Database Referencing of Array Genes Online , 2000, Bioinform..

[19]  C. Finch,et al.  Glial Fibrillary Acidic Protein: Regulation by Hormones, Cytokines, and Growth Factors , 1994, Brain pathology.

[20]  Christian A. Rees,et al.  Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  T. Matsuishi,et al.  Mutation analysis of the methyl-CpG binding protein 2 gene (MECP2) in patients with Rett syndrome , 2000, Journal of medical genetics.

[22]  H. Zoghbi,et al.  Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. , 1999, American journal of human genetics.

[23]  I. Levitan,et al.  A Dynamically Regulated 14–3–3, Slob, and Slowpoke Potassium Channel Complex in Drosophila Presynaptic Nerve Terminals , 1999, Neuron.

[24]  J. Rostas,et al.  Subcellular Localisation of 14‐3‐3 Isoforms in Rat Brain Using Specific Antibodies , 1994, Journal of Neurochemistry.

[25]  H. Marks,et al.  Detection of new paternal dystrophin gene mutations in isolated cases of dystrophinopathy in females. , 1994, American journal of human genetics.

[26]  Pat Levitt,et al.  Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex , 2000, Neuron.

[27]  J. Pevsner,et al.  High throughput analysis of gene expression in the human brain , 2000, Journal of Neuroscience Research.

[28]  J. Clayton-Smith,et al.  Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males , 2000, The Lancet.

[29]  E. Cook,et al.  Novel de novo nonsense mutation of MECP2 in a patient with Rett syndrome , 2000, Human mutation.

[30]  J. Lowe,et al.  The cortical neuritic pathology of Huntington's disease , 1995, Neuropathology and applied neurobiology.

[31]  S. Reed,et al.  Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. , 2000, Cancer research.

[32]  Y. Sakaki,et al.  Alpha B-crystallin and 27-kd heat shock protein are regulated by stress conditions in the central nervous system and accumulate in Rosenthal fibers. , 1993, The American journal of pathology.

[33]  R. Jaenisch,et al.  Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice , 2001, Nature Genetics.

[34]  C. Woods,et al.  Mutations in the MECP2 gene in a cohort of girls with Rett syndrome , 2000, Journal of medical genetics.

[35]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[36]  T. Iwaki,et al.  Alpha B-crystallin is expressed in non-lenticular tissues and accumulates in Alexander's disease brain. , 1989, Cell.

[37]  J. Pevsner,et al.  Postmortem brain abnormalities of the glutamate neurotransmitter system in autism , 2001, Neurology.

[38]  W. D. de Jong,et al.  Expression of alpha B-crystallin in Alzheimer's disease. , 1994, Acta neuropathologica.

[39]  D. Armstrong.  Review of Rett Syndrome , 1997, Journal of neuropathology and experimental neurology.

[40]  A. Silahtaroglu,et al.  MECP2 mutations in Danish patients with Rett syndrome: High frequency of mutations but no consistent correlations with clinical severity or with the X chromosome inactivation pattern , 2001, European Journal of Human Genetics.

[41]  A. Munnich,et al.  MECP2 mutation in non-fatal, non-progressive encephalopathy in a male , 2001, Journal of medical genetics.

[42]  A. Bird,et al.  MeCP2 Is a Transcriptional Repressor with Abundant Binding Sites in Genomic Chromatin , 1997, Cell.

[43]  J. P. Schwartz,et al.  Cell culture models for reactive gliosis: New perspectives , 1998, Journal of neuroscience research.

[44]  W. Kaufmann,et al.  Quantitative 1H MR spectroscopic imaging in early Rett syndrome , 2000, Neurology.

[45]  H. Zoghbi,et al.  Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations. , 2000, American journal of medical genetics.

[46]  D. Lewis,et al.  Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia , 2001, Molecular Psychiatry.

[47]  H. Zoghbi,et al.  Diagnostic testing for Rett syndrome by DHPLC and direct sequencing analysis of the MECP2 gene: identification of several novel mutations and polymorphisms. , 2000, American journal of human genetics.

[48]  A Aitken,et al.  Expression and structural analysis of 14-3-3 proteins. , 1995, Journal of molecular biology.

[49]  H. Cedar.  DNA methylation and gene activity , 1988, Cell.

[50]  R. Narayanan,et al.  Microarray-based expression profiling in prostate tumors. , 2000, In vivo.

[51]  P. Huppke,et al.  Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients. , 2000, Human molecular genetics.

[52]  M. Bittner,et al.  Expression profiling in cancer using cDNA microarrays , 1999, Electrophoresis.

[53]  H. Zoghbi,et al.  Methyl-CpG-binding protein 2 mutations in Rett syndrome. , 2000, Current opinion in genetics & development.

[54]  L. Svennerholm,et al.  Membrane cerebral lipids in Rett syndrome. , 1991, Pediatric neurology.

[55]  H. Zoghbi,et al.  Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes , 2000, Annals of neurology.

[56]  J. Clayton-Smith,et al.  Angelman syndrome phenotype associated with mutations inMECP2, a gene encoding a methyl CpG binding protein , 2001, Journal of medical genetics.

[57]  T. Watanabe,et al.  Annexin VI Binds to a Synaptic Vesicle Protein, Synapsin I , 1994, Journal of neurochemistry.

[58]  R. Mayer,et al.  αB crystallin expression in nonlenticular tissues and selective presence in ubiquitinated inclusion bodies in human disease , 1992, The Journal of pathology.

[59]  J. Goldman,et al.  Overexpression and abnormal modification of the stress proteins alpha B-crystallin and HSP27 in Alexander disease. , 1993, The American journal of pathology.

[60]  J. Fryns,et al.  A mutation in the rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. , 2000, American journal of human genetics.

[61]  M. Anvret,et al.  Mutation screening in Rett syndrome patients , 2000, Journal of medical genetics.

[62]  Jean Aicardi,et al.  A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: Report of 35 cases , 1983, Annals of neurology.

[63]  K. Yamakawa,et al.  Mutational analysis of the MECP2 gene in Japanese patients with Rett syndrome , 2000, Journal of Human Genetics.

[64]  N. Sampas,et al.  Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.

[65]  G. Bosman,et al.  Dementia, gliosis and expression of the small heat shock proteins hsp27 and alpha B-crystallin in Parkinson's disease. , 1999, Neuroreport.

[66]  W H Wong,et al.  Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Ronald L. Davis,et al.  Leonardo, a Drosophila 14-3-3 Protein Involved in Learning, Regulates Presynaptic Function , 1997, Neuron.

[68]  A. Razin,et al.  CpG methylation, chromatin structure and gene silencing—a three‐way connection , 1998, The EMBO journal.

[69]  T. Iwaki,et al.  αB-crystallin is expressed in non-lenticular tissues and accumulates in Alexander's disease brain , 1989, Cell.

[70]  J. Herman,et al.  Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer , 1999, Nature Genetics.

[71]  Y. L. Lee,et al.  Astrocytes cultured from transgenic mice carrying the added human glial fibrillary acidic protein gene contain rosenthal fibers , 1998, Journal of neuroscience research.

[72]  K. Jellinger,et al.  Neuropathology of Rett syndrome , 2004, Acta Neuropathologica.

[73]  A. Dahlström,et al.  Morphological study of neocortical areas in Rett syndrome , 1996, Acta Neuropathologica.

[74]  P. Storz,et al.  Protein Kinase C μ Is Negatively Regulated by 14-3-3 Signal Transduction Proteins* , 1999, The Journal of Biological Chemistry.

[75]  L. Hood,et al.  Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. , 1999, Gene.

[76]  A. Bird,et al.  A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome , 2001, Nature Genetics.

[77]  Ash A. Alizadeh,et al.  The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. , 1999, Cold Spring Harbor symposia on quantitative biology.

[78]  G. Pearlson,et al.  The neuroanatomy of Rett syndrome: Neuropathological and neuroimaging studies , 1998 .

[79]  D. Cooper,et al.  Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. , 2000, Human molecular genetics.

[80]  J Dragich,et al.  Rett syndrome: a surprising result of mutation in MECP2. , 2000, Human molecular genetics.

[81]  H. Zoghbi,et al.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.

[82]  T. Kemper,et al.  Microscopic Observations of the Brain in Rett Syndrome , 1995, Neuropediatrics.

[83]  T. Iwaki,et al.  Rosenthal fibers share epitopes with alpha B-crystallin, glial fibrillary acidic protein, and ubiquitin, but not with vimentin. Immunoelectron microscopy with colloidal gold. , 1991, The American journal of pathology.

[84]  B Pickard,et al.  Imprinting mechanisms. , 1998, Genome research.

[85]  B. Hagberg,et al.  Rett syndrome: cerebellar pathology. , 1990, Pediatric neurology.

[86]  W. Kaufmann,et al.  Abnormal expression of microtubule-associated protein 2 (MAP-2) in neocortex in Rett syndrome. , 1995, Neuropediatrics.

[87]  H. Ropers,et al.  MECP2 is highly mutated in X-linked mental retardation. , 2001, Human molecular genetics.

[88]  J. Goldman,et al.  Rosenthal fibers contain ubiquitinated alpha B-crystallin. , 1991, The American journal of pathology.

[89]  F. Vitelli,et al.  Preserved speech variant is allelic of classic Rett syndrome , 2000, European Journal of Human Genetics.

[90]  K. Jellinger.  Cell death mechanisms in Parkinson's disease , 2000, Journal of Neural Transmission.

[91]  R. Mayer,et al.  Ballooned neurons in several neurodegenerative diseases and stroke contain αB crystallin , 1992 .

[92]  W. V. van Blitterswijk,et al.  Protein kinase C activation by acidic proteins including 14-3-3. , 2000, The Biochemical journal.

[93]  C. Gillberg,et al.  Glial fibrillary acidic protein in the cerebrospinal fluid of children with autism and other neuropsychiatric disorders , 1993, Biological Psychiatry.

[94]  H. Nordgren,et al.  Rett syndrome: spinal cord neuropathology. , 1988, Pediatric neurology.

[95]  W. Doerfler,et al.  DNA methylation and gene activity. , 1983, Annual review of biochemistry.

[96]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[97]  T. Kemper,et al.  Pervasive neuroanatomic abnormalities of the brain in three cases of Rett's syndrome , 1995, Neurology.

[98]  Colin A. Johnson,et al.  Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex , 1998, Nature.